Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
152,309,909
-
Number of holders
-
522
-
Total 13F shares, excl. options
-
152,193,816
-
Shares change
-
+1,025,897
-
Total reported value, excl. options
-
$10,358,362,931
-
Value change
-
+$40,449,398
-
Put/Call ratio
-
43.39%
-
Number of buys
-
227
-
Number of sells
-
-268
-
Price
-
$68.07
Significant Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) as of Q3 2023
596 filings reported holding TECH - BIO-TECHNE Corp - COMMON STOCK as of Q3 2023.
BIO-TECHNE Corp - COMMON STOCK (TECH) has 522 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 152,193,816 shares
of 152,309,909 outstanding shares and own 99.92% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (18,354,669 shares), BlackRock Inc. (18,281,061 shares), STATE STREET CORP (6,218,410 shares), BAMCO INC /NY/ (5,375,959 shares), Select Equity Group, L.P. (4,876,036 shares), PRICE T ROWE ASSOCIATES INC /MD/ (3,857,666 shares), Neuberger Berman Group LLC (3,724,068 shares), GEODE CAPITAL MANAGEMENT, LLC (3,618,507 shares), DF DENT & CO INC (3,349,047 shares), and MORGAN STANLEY (3,305,826 shares).
This table shows the top 522 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.